Lung disease Clinical Trials
Recruiting lung disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat lung disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting lung disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting lung disease trials
Chronic COUGH Management in Interstitial Lung DisEase
RSV Vaccination to Reduce Recurrent AECOPD
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
Pulmonary Rehabilitation Frequency in COPD Patients
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
Dose-Escalation Study of Artesunate Patients With IPF
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines
SMART-School-based Asthma Therapy
Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
Effect of add-on Doxofylline on Lung Function in Stable COPD
Portable Positive Pressure Therapy Device
Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study
THERMotherapy Against Persistent Bacterial LUNG Infections
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC
Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Vapor Ablation for Localized Cancer Lesions
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
Immuno-inflammatory Response of Erdosteine in COPD
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Screening and Management of Adults With Asthma and Allergic Diseases
Dynamic Changes in Right Ventricle and Pulmonary Artery Coupling Among COPD Patients With Acute Exacerbation
Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis
TEPH: Telaglenastat Efficacy in Pulmonary Hypertension
Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function
Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)
A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Pulmonary Hypertension (PH) Biorepository for Translational Research
SBAT for Health Equity
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers
Outpatient Rehabilitation Programmes for Myocardial Ischemia, Heart Failure, and COPD: Satisfaction, Participation, Test Outcomes, and Factors Associated With Positive Changes in Test Results as Well as Level of Participation
Effect of Vasopressin Versus Norepinephrine on Post-operative Mean Pulmonary Arterial Pressure Following Pulmonary Endarterectomy Surgery,
Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial Prospective
Two-Point Versus Single-Point Serratus Anterior Plane Block for Post-Thoracoscopic Surgery Analgesia
Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
Improving the Quality of Care for Asthma Patients at Risk of Exacerbations
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
AIRCARE (Air Pollution and Cancer Research Ecosystem): Center for Advanced Research on Environmental Health and Lung Cancer Risk
MedlyPeds Feasibility Study
A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension
Observational Study That Will Analyse the Spread and Stratification of Lung Cancer Risk Using Artificial Intelligence
A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease
Lung disease clinical trials — common questions
Are lung disease clinical trials free to join?
Yes. Participating in a lung disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a lung disease clinical trial?
Each lung disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a lung disease trial near me?
Use the location controls above. We'll show recruiting lung disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many lung disease trials are recruiting right now?
We're currently tracking roughly 561 recruiting lung disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.